Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
11.52
-0.15 (-1.28%)
Jul 27, 2026, 10:15 AM EDT - Market open
Core Laboratories Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 531 | 739 | 811 | 827 | 945 | 1,034 | |
Market Cap Growth | -10.24% | -8.84% | -2.04% | -12.46% | -8.59% | -12.49% |
Enterprise Value | 682.97 | 886.45 | 977.3 | 1,033 | 1,157 | 1,271 |
Last Close Price | 11.52 | 16.03 | 17.31 | 17.66 | 20.27 | 22.31 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.95 | 25.44 | 26.23 | 22.94 | 48.26 | 53.12 |
Forward PE | 23.75 | 21.66 | 18.55 | 17.98 | 23.39 | 24.73 |
PEG Ratio | 3.04 | 14.84 | 0.99 | 0.36 | - | - |
PS Ratio | 1.03 | 1.40 | 1.55 | 1.62 | 1.93 | 2.20 |
PB Ratio | 2.00 | 2.78 | 3.29 | 3.68 | 5.13 | 6.61 |
P/TBV Ratio | 3.45 | 4.93 | 5.87 | 7.09 | 12.27 | 21.32 |
P/FCF Ratio | 29.18 | 32.93 | 18.69 | 58.23 | 64.13 | 44.88 |
P/OCF Ratio | 15.67 | 19.95 | 14.37 | 33.38 | 37.88 | 28.27 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.30 | 1.68 | 1.87 | 2.03 | 2.36 | 2.70 |
EV/EBITDA Ratio | 9.95 | 12.46 | 13.30 | 14.66 | 19.71 | 19.93 |
EV/EBIT Ratio | 12.66 | 15.70 | 16.69 | 18.90 | 27.86 | 28.08 |
EV/FCF Ratio | 37.05 | 39.50 | 22.54 | 72.68 | 78.49 | 55.17 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.57 | 0.56 | 0.67 | 0.89 | 1.12 | 1.48 |
Debt / EBITDA Ratio | 2.44 | 2.31 | 2.45 | 3.06 | 3.79 | 3.92 |
Debt / FCF Ratio | 9.11 | 7.31 | 4.16 | 15.16 | 15.09 | 10.86 |
Net Debt / Equity Ratio | 0.54 | 0.53 | 0.65 | 0.89 | 1.12 | 1.49 |
Net Debt / EBITDA Ratio | 2.11 | 1.99 | 2.19 | 2.84 | 3.53 | 3.65 |
Net Debt / FCF Ratio | 7.87 | 6.30 | 3.71 | 14.09 | 14.04 | 10.09 |
Asset Turnover | 0.90 | 0.90 | 0.89 | 0.88 | 0.84 | 0.70 |
Inventory Turnover | 7.48 | 7.33 | 6.42 | 6.05 | 7.44 | 8.80 |
Quick Ratio | 1.25 | 1.29 | 1.28 | 1.41 | 1.19 | 1.26 |
Current Ratio | 2.05 | 2.02 | 2.16 | 2.53 | 2.05 | 2.08 |
Return on Equity (ROE) | 10.80% | 11.59% | 13.34% | 17.68% | 11.23% | 9.85% |
Return on Assets (ROA) | 6.32% | 6.40% | 6.96% | 8.43% | 4.70% | 3.79% |
Return on Invested Capital (ROIC) | 8.88% | 9.04% | 9.67% | 11.89% | 6.90% | 7.27% |
Return on Capital Employed (ROCE) | 11.23% | 11.76% | 11.94% | 11.23% | 8.60% | 7.86% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.40% | 3.93% | 3.81% | 4.36% | 2.07% | 1.88% |
FCF Yield | 3.43% | 3.04% | 5.35% | 1.72% | 1.56% | 2.23% |
Dividend Yield | 0.34% | 0.25% | 0.23% | 0.23% | 0.20% | 0.18% |
Payout Ratio | 6.49% | 6.30% | 5.97% | 5.09% | 9.53% | 9.30% |
Buyback Yield / Dilution | 1.26% | 1.38% | -0.34% | -1.52% | -0.26% | -4.98% |
Total Shareholder Return | 1.61% | 1.63% | -0.11% | -1.29% | -0.07% | -4.80% |